Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 7—July 2009

Conference Summary

Materials Available Online Only

Meeting on Establishment of Consortium to Study Invasive Salmonelloses in Sub-Saharan Africa

John D. ClemensComments to Author 
Author affiliation: Author affiliation: International Vaccine Institute, Seoul, Republic of Korea

Main Article

Table

Characteristics of fever surveillance sites presented during meeting to form a fever surveillance consortium in sub-Saharan Africa, Kilifi, Kenya, January 24, 2009*

Location Type of surveillance Age group Inclusion criteria Laboratory tests
Agogo, Republic of Ghana (rural)
Hospital-based, passive
>2 m
History of (72 h) or acute fever and severe disease
Blood culture, malaria smear
Kilifi, Kenya (rural)
Hospital-based, passive
Pediatric population
All pediatric admissions
Blood culture, HIV test, malaria smear
Bamako, Mali (urban and rural)
Hospital-based, passive
0–15 y
Fever >39°C, clinical syndrome suggestive of invasive bacterial disease
Blood culture, malaria smear
Lambaréné, Gabon (rural)
Hospital-based, passive
All ages (at physicians request)
Severe disease with fever
Blood culture, HIV test, malaria smear
Muheza, Tanzania (rural)
Hospital-based, passive
2 m–14 y
History of (72 h) or acute fever and severe disease
Blood culture, HIV test, malaria smear
Moshi, Tanzania (urban and rural)
Hospital-based, passive
>2 mo
Child: history (72 h) or acute fever and severe disease; Adult: fever >38.0°C (oral)
Blood culture, HIV test, malaria smear
Nairobi, Kenya (urban)
Population-based, active with household- and clinic-based surveillance
All ages
Fever >38.5°C or suspected severe pneumonia
Blood culture, malaria smear, HIV test, NP/OP swabs of patients meeting pneumonia or influenza criteria
Pemba, Zanzibar (rural)
Hospital-based, passive
>2 mo
Fever >3 d
Blood culture, HIV test, malaria smear
Abuja, Nigeria (urban and rural)
Hospital based, passive
2–59 mo
Fever <14 d
Blood culture, malaria smear, HIV test, APR
Blantyre, Malawi (urban and rural)
Hospital-based, passive
Few neonates; largely >2 mo
Any nonmalarial febrile illness/ suspicion of invasive bacterial infection
Blood culture, CSF, HIV test, malaria smear, radiology, sputum smear and culture
South Africa (countrywide) Active laboratory surveillance All ages NA; all invasive/noninvasive salmonellae isolated Specimen culture

*NP, nasopharyngeal; OP, oropharyngeal; APR, acute-phase reactant; CSF, cerebrospinal fluid; NA, not available.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO